LYTIR

Company · RMD

ResMed Inc.

Name as listed on its exchange; filed with the SEC as RESMED INC.

Nasdaq's symbol directory lists RMD on the New York Stock Exchange as “ResMed Inc. Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 10 occasions ($8.7M); 9 planned-sale notices; 1 filing by holders of 5% or more; 11 congressional trade disclosures; 5 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $8.7M in total.Jun: Insider sales $968KJul: Insider sales $1.1MAug: Insider sales $2.8MSep: Insider sales $1.3MOct: Insider sales $1.2MNov: Insider sales $1.3MDecJanFebMarAprMayJunJulAugSepOctNov$2.8M
Insider purchases above the line: $0Insider sales below: $8.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Michael J. Farrell, Chairman and CEO sold on 6 days all under a 10b5-1 plan latest Nov 9, 2026 sold $6.5M
  2. Peter C. Farrell sold on 2 days all under a 10b5-1 plan latest Sep 2, 2026 sold $2.0M
  3. Rider Michael J, Global General Counsel sold on 1 day all under a 10b5-1 plan latest Oct 23, 2026 sold $102K
  4. De Witte Jan sold on 1 day all under a 10b5-1 plan latest Nov 17, 2026 sold $102K
Every trade (10)
  1. SELLDe Witte Jan sold Nov 17, 2026 429 shares 10b5-1 plan (scheduled) filing $102K
  2. SELLMichael J. Farrell, Chairman and CEO sold Nov 9, 2026 4,993 shares 10b5-1 plan (scheduled) filing $1.2M
  3. SELLRider Michael J, Global General Counsel sold Oct 23, 2026 400 shares 10b5-1 plan (scheduled) filing $102K
  4. SELLMichael J. Farrell, Chairman and CEO sold Oct 7, 2026 4,991 shares 10b5-1 plan (scheduled) filing $1.1M
  5. SELLMichael J. Farrell, Chairman and CEO sold Sep 8, 2026 4,991 shares 10b5-1 plan (scheduled) filing $1.1M
  6. SELLPeter C. Farrell sold Sep 2, 2026 970 shares 10b5-1 plan (scheduled) filing $228K
  7. SELLMichael J. Farrell, Chairman and CEO sold Aug 7, 2026 4,991 shares 10b5-1 plan (scheduled) filing $1.0M
  8. SELLPeter C. Farrell sold Aug 5, 2026 8,000 shares 10b5-1 plan (scheduled) filing $1.8M
  9. SELLMichael J. Farrell, Chairman and CEO sold Jul 7, 2026 4,991 shares 10b5-1 plan (scheduled) filing $1.1M
  10. SELLMichael J. Farrell, Chairman and CEO sold Jun 8, 2026 4,991 shares 10b5-1 plan (scheduled) filing $968K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. De Witte Jan filed Nov 17, 2026 Director 429 shares planned sale date 11/17/2026 filing $102K
  2. Farrell Michael J. filed Nov 9, 2026 Officer 4,993 shares planned sale date 11/09/2026 filing $1.2M
  3. Rider Michael J filed Oct 23, 2026 Officer 400 shares planned sale date 10/23/2026 filing $102K
  4. Farrell Michael J. filed Oct 7, 2026 Officer 4,991 shares planned sale date 10/07/2026 filing $1.1M
  5. Farrell Michael J. filed Sep 8, 2026 Officer 4,991 shares planned sale date 09/08/2026 filing $1.1M
  6. Peter C Farrell filed Sep 2, 2026 Director 970 shares planned sale date 09/02/2026 filing $228K
  7. Farrell Michael J. filed Aug 7, 2026 Officer 4,991 shares planned sale date 08/07/2026 filing $1.0M
  8. Peter C Farrell filed Aug 5, 2026 Director 8,000 shares planned sale date 08/05/2026 filing $1.8M
  9. Farrell Michael J. filed Jul 7, 2026 Officer 4,991 shares planned sale date 07/07/2026 filing $1.1M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. AustralianSuper Pty Ltd filed Aug 7, 2026 Schedule 13G passive 8,276,381 shares filing 5.7%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Rohit Khanna (D-CA17): Purchase Sep 11, 2026 reported Oct 7, 2026 one of 325 trades the member reported that day House owner: dependent $1,001 - $15,000
  2. Rohit Khanna (D-CA17): Sale Jun 30, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: spouse $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase Jun 16, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: spouse $1,001 - $15,000
  4. Rohit Khanna (D-CA17): Sale May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  5. Rohit Khanna (D-CA17): Purchase May 1, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: dependent $1,001 - $15,000
  6. Rohit Khanna (D-CA17): Purchase Apr 24, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $1,001 - $15,000
  7. Rohit Khanna (D-CA17): Sale Mar 30, 2026 reported Apr 7, 2026 one of 274 trades the member reported that day House owner: dependent $1,001 - $15,000
  8. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  9. Rohit Khanna (D-CA17): Purchase Feb 24, 2026 reported Mar 9, 2026 one of 274 trades the member reported that day House owner: dependent $1,001 - $15,000
  10. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000
  11. Rohit Khanna (D-CA17): Sale Jan 23, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

13 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Sale: RESMED INC Aug 26, 2026 reported Sep 17, 2026 President Donald J. Trump Periodic Transaction Report 09.17.26 $15,001 – $50,000
  2. Sale: RESMED INC Jul 8, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $1,001 – $15,000
  3. Sale: RESMED INC Jun 24, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $50,001 – $100,000
  4. Purchase: RESMED INC Jun 23, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  5. Purchase: RESMED INC Jun 3, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  6. Purchase: RESMED INC May 22, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $50,001 – $100,000
  7. Sale: RESMED INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  8. Sale: RESMED INC May 11, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $15,001 – $50,000
  9. Sale: RESMED INC Apr 28, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $1,001 – $15,000
  10. Purchase: RESMED INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000

Showing the latest 10 of 13.

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Other events filing Oct 29, 2026
  2. Other events filing Sep 1, 2026
  3. Change in certifying accountant; Departure or appointment of directors or officers; Regulation FD disclosure filing Aug 17, 2026
  4. Results of operations and financial condition; Other events filing Aug 6, 2026
  5. Results of operations and financial condition; Regulation FD disclosure filing Jul 7, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K), OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.